Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis

Title
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis
Authors
Keywords
myeloma, MRD, ASO-RQ-PCR, novel agents, flow cytometry
Journal
Oncotarget
Volume 8, Issue 4, Pages -
Publisher
Impact Journals, LLC
Online
2016-10-14
DOI
10.18632/oncotarget.12641

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search